BioMarin Pharma (BMRN) Reports Q4 Adj-EPS of 10c; Guides FY11 Sales

February 17, 2011 4:26 PM

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported Q4 EPS of $0.10 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found